New expectations in the treatment of anemia in chronic kidney disease
Juan M. López-Gómez, Soraya Abad, Almudena Vega
Nefrología (English Edition) · 2016
doi:10.1016/j.nefroe.2016.07.002 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
The new drugs developed for the treatment of anemia in chronic kidney disease patients, together with their mechanisms of action are reviewed. At present, many of them are already in advanced stages of clinical trials and is expected to be incorporated into the therapeutic arsenal in the coming years. The potential benefits and possible limitations are also described.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.